Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.57−0.08 (-1.50%)
Close on Nov 17, 2026Market cap $482.87MP/E –Yield –
Valneva price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Valneva's price to sales ratio was 3.5× on Nov 11, 2026, against 3.1× a year earlier. Over the last 3 years it ranged from 1.5× to 23.5×, with a median of 3.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.5× | +0.0 |
| 2025 | Oct 31, 2025 | 3.5× | +0.3 |
| 2024 | Apr 30, 2024 | 3.1× | +1.5 |
| 2023 | Apr 28, 2023 | 1.6× | −0.4 |
| 2022 | Oct 31, 2022 | 2.0× | −18.2 |
| 2021 | Dec 31, 2021 | 20.2× | – |
See a number that looks wrong?